Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps

International Forum of Allergy and Rhinology

Volumn 4, Issue 6, 2014, Pages 453-462

  Chen, Daishi ^a   Mao, Mingfeng ^a   Bellussi, Luisa M ^b   Passali, Desiderio ^b   Chen, Lei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Chinese patients; Chronic rhinosinusitis with nasal polyps; Cytokine; Eosinophilic inflammation; HMGB1 protein

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 5; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC SINUS SURGERY; EOSINOPHIL COUNT; ETHMOID SINUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NASAL BIOPSY; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ADOLESCENT; AGED; CELL MOTION; CHINA; CHRONIC DISEASE; EOSINOPHIL; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NOSE MUCOSA; RHINITIS; SINUSITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CELL MOVEMENT; CHINA; CHRONIC DISEASE; CYTOKINES; EOSINOPHILS; FEMALE; HMGB1 PROTEIN; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS; UP-REGULATION; YOUNG ADULT;

EID: 84901818372     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21294     Document Type: Article

References (40)

1. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;(23):1-298.
2. Van Crombruggen K, Zhang N, Gevaert P, et al. Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol. 2011;128:728-732.
3. Van Bruaene N, Pérez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121:1435-1441.
4. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124:478-484.
5. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122:961-968.
6. Kim JW, Hong SL, Kim YK, et al. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg. 2007;137:925-930.
7. Sejima T, Holtappels G, Kikuchi H, et al. Cytokine profiles in Japanese patients with chronic rhinosinusitis. Allergol Int. 2012;61:115-122.
8. Scaffidi P, Mistell T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-195.
9. Müller S, Scaffidi P, Degryse B, et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 2001;20:4337-4340.
10. Liu Y, Prasad R, Wilson, SH. HMGB1: roles in base excision repair and related function. Biochim Biophys Acta. 2010;1799:119-130.
11. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 2006;17:189-201.
12. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248-251.
13. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565-570.
14. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med. 2005;33:564-573.
15. Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181:917-927.
16. Jiang W, Pisetsky DS. Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis. 2008;67:727-728.
17. Li J, Xie H, Wen T, et al. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus. J Rheumatol. 2010;37:766-775.
18. Goldstein RS, Bruchfeld A, Yang L, et al. Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med. 2007;13:210-215.
19. Popovic K, Ek M, Espinosa A, et al. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 2005;52:3639-3645.
20. Duan L, Wang CY, Chen J, et al. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Lab Invest. 2011;91:43-53.
21. Lotfi R, Herzog GI, DeMarco RA, et al. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol. 2009;183:5023-5031.
22. Sugars R, Karlström E, Christersson C, et al. Expression of HMGB1 during tooth development. Cell Tissue Res. 2007;327:511-519.
23. Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol. 2001;152:1197-2006.
24. Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35-46.
25. Liu Y, Wang ZB, Liu Z, et al. The expression of HMGB1 in nasal mucosa of allergic rhinitis patients and its significance. Zhong Hua Mian Yi Xue Za Zhi. 2010;26:651-654.
26. Shim EJ, Chun E, Lee HS, et al. The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma. Clin Exp Allergy. 2012;42:958-965.
27. Bellussi LM, Chen L, Chen D, et al. The role of high mobility group box 1 chromosomal protein in the pathogenesis of chronic sinusitis and nasal polyposis. Acta Otorhinolaryngol Ital. 2012;32:386-392.
28. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:S35-S40.
29. Brozek JL, Bousquet J, Baena-Cagnani CE, et al.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466-476.
30. de Castro MC, Rocha-Silva F, Gomes LI, et al. Impact of mitomycin C on the mRNA expression signatures of immunological biomarkers in eosinophilic nasal polyposis. Am J Rhinol Allergy. 2013;27:e32-e41.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
32. Ek M, Popovic K, Harris HE, et al. Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjogren's syndrome. Arthritis Rheum. 2006;54:2289-2294.
33. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol. 2009;124:37-42.
34. Chen D, Bellussi LM, Passali D, Chen L. LPS may enhance HMGB1 expression and release in human nasal epithelial cells in vitro. Acta Otorhinolaryngol Ital. 2013;33:406-412.
35. Shi Y, Sandoghchian-Sotorbani S, Su Z, et al. Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis. Clin Dev Immunol. 2012;2012:295081.
36. Curtin JF, Liu N, Candolfi M, et al. HMGB1 mediates endogenous TLR2 activation and brain and brain tumor regression. PloS Med. 2009;6:e10.
37. Bauer S, Hangel D, Yu P. Immunobiology of toll-like receptors in allergic disease. Immunobiology. 2007;212:521-533.
38. Dong Z, Yang Z, Wang C, et al. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am J Rhinol. 2005;19:236-239.
39. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1-136.
40. Ishitoya J, Sakuma Y, Tsukuda M. Eosinophilic chronic rhinosinusitis in Japan. Allergol Int. 2010;59:239-245.